Logo for Iterum Therapeutics plc

Iterum Therapeutics Investor Relations Material

Latest events

Logo for Iterum Therapeutics plc

Q4 2024

Iterum Therapeutics
Logo for Iterum Therapeutics

Q4 2024

7 Feb, 2025
Logo for Iterum Therapeutics

Q3 2024

14 Nov, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies

Latest reports from Iterum Therapeutics plc

Access all reports
Iterum Therapeutics plc is a clinical-stage pharmaceutical company focused on developing novel anti-infective therapies. The company is working on next-generation oral and intravenous antibiotics designed to combat infections caused by multi-drug resistant pathogens, which are a growing global health concern. Iterum's lead product candidate, sulopenem, is a novel penem antibiotic that has shown potent activity against a broad spectrum of bacteria, including strains that are resistant to other antibiotics. Iterum Therapeutics is headquartered in Dublin, Ireland, and its shares are listed on the NASDAQ.